We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 23, 2011

The Medicines Company v. Mylan Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. October 30, 2017

    Mylan Scores Costs After Win In Blood-Thinner IP Row

    Mylan on Monday scored nearly all of the litigation costs it requested in a six-year dispute with The Medicines Co. over a generic version for the blood-thinner Angiomax, with an Illinois federal judge awarding $217,632 after the Federal Circuit found Mylan's generic did not infringe TMC's patents.

3 other articles on this case. View all »


To view the parties, register now.